Suven Life Sciences [SUVEN] vs Hester Biosciences [HESTERBIO] Detailed Stock Comparison

Suven Life Sciences Ltd.

NSE
Loading...

Hester Biosciences Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Suven Life Sciences Ltd. wins in 5 metrics, Hester Biosciences Ltd. wins in 12 metrics, with 1 ties. Hester Biosciences Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Suven Life Sciences Ltd. Hester Biosciences Ltd. Better
P/E Ratio (TTM) -27.46 30.37 Hester Biosciences Ltd.
Price-to-Book Ratio 16.79 3.73 Hester Biosciences Ltd.
Debt-to-Equity Ratio 0.00 60.85 Tie
PEG Ratio -0.18 -1.65 Suven Life Sciences Ltd.
EV/EBITDA -16.05 19.66 Hester Biosciences Ltd.
Profit Margin (TTM) 84.44% 12.97% Suven Life Sciences Ltd.
Operating Margin (TTM) -3,727.57% 17.26% Hester Biosciences Ltd.
EBITDA Margin (TTM) N/A 17.26% N/A
Return on Equity -146.15% 8.41% Hester Biosciences Ltd.
Return on Assets (TTM) -118.91% 4.21% Hester Biosciences Ltd.
Free Cash Flow (TTM) $-1.91B $439.20M Hester Biosciences Ltd.
Dividend Yield N/A 0.64% N/A
1-Year Return 13.65% 5.05% Suven Life Sciences Ltd.
Price-to-Sales Ratio (TTM) 794.04 3.96 Hester Biosciences Ltd.
Enterprise Value $44.58B $14.12B Suven Life Sciences Ltd.
EV/Revenue Ratio 631.27 4.47 Hester Biosciences Ltd.
Gross Profit Margin (TTM) 100.00% 73.22% Suven Life Sciences Ltd.
Revenue per Share (TTM) $0 $369 Hester Biosciences Ltd.
Earnings per Share (Diluted) $-12.31 $48.41 Hester Biosciences Ltd.
Beta (Stock Volatility) 0.30 0.22 Hester Biosciences Ltd.

Suven Life Sciences Ltd. vs Hester Biosciences Ltd. Stock Performance Analysis

Loading Price Chart...

SUVEN
HESTERBIO

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Suven Life Sciences Ltd.0.60%15.54%27.80%96.81%52.40%63.85%
Hester Biosciences Ltd.5.82%5.27%12.84%43.52%29.64%29.64%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Suven Life Sciences Ltd.13.65%309.23%215.11%2,691.36%26,459.41%157,694.12%
Hester Biosciences Ltd.5.05%19.30%-22.79%198.65%322.75%322.75%

Performance & Financial Health Analysis: Suven Life Sciences Ltd. vs Hester Biosciences Ltd.

MetricSUVENHESTERBIO
Market Information
Market Cap i₹53.28B₹12.57B
Market Cap CategoryMid capSmall cap
10 Day Avg. Volume i733,6793,341
90 Day Avg. Volume i644,0244,944
Last Close₹269.85₹2,066.60
52 Week Range₹124.11 - ₹299.99₹1,239.30 - ₹2,350.00
% from 52W High-10.05%-12.06%
All-Time High₹338.50 (Apr 13, 2015)₹3,379.00 (Jul 22, 2024)
% from All-Time High-20.28%-38.84%
Growth Metrics
Quarterly Revenue Growth0.75%0.09%
Quarterly Earnings Growth0.74%-0.25%
Financial Health
Profit Margin (TTM) i0.84%0.13%
Operating Margin (TTM) i-37.28%0.17%
Return on Equity (TTM) i-1.46%0.08%
Debt to Equity (MRQ) i0.0060.85
Cash & Liquidity
Book Value per Share (MRQ)₹12.66₹394.06
Cash per Share (MRQ)₹11.50₹9.91
Operating Cash Flow (TTM) i₹-1,590,282,000₹554.94M
Levered Free Cash Flow (TTM) i₹-1,607,450,000₹274.88M
Dividends
Last 12-Month Dividend Yield iN/A0.64%
Last 12-Month Dividend i₹0.00₹13.00

Valuation & Enterprise Metrics Analysis: Suven Life Sciences Ltd. vs Hester Biosciences Ltd.

MetricSUVEN (Apr 24, 2026)HESTERBIO (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-27.4630.37
Forward P/E i10.99N/A
PEG Ratio i-0.18-1.65
Price to Sales (TTM) i794.043.96
Price to Book (MRQ) i16.793.73
Market Capitalization
Market Capitalization i₹53.28B₹12.57B
Enterprise Value i₹44.58B₹14.12B
Enterprise Value Metrics
Enterprise to Revenue i631.274.47
Enterprise to EBITDA i-16.0519.66
Risk & Other Metrics
Beta i0.300.22
Book Value per Share (MRQ) i₹12.66₹394.06

Financial Statements Comparison: Suven Life Sciences Ltd. vs Hester Biosciences Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSUVEN (2025)HESTERBIO (2025)
Revenue/Sales i66.56M3.11B
Cost of Goods Sold i10.36M1.03B
COGS % of Revenue i15.6%33.0%
Gross Profit i56.20M2.08B
Gross Margin i84.4%67.0%
Research & Development i1.44BN/A
Operating Income (EBIT) i-1.71B452.43M
Operating Margin i-2,572.9%14.5%
EBITDA i-1.60B651.99M
EBITDA Margin i-2,401.7%21.0%
Pre-Tax Income i-1.61B395.71M
Pre-Tax Income % of Revenue i-2,415.1%12.7%
Income Tax i0107.45M
Income Tax % of Revenue i0.0%3.5%
Net Income (Profit) i-1.61B288.26M
Profit Margin i-2,415.1%9.3%

Balance Sheet & Liquidity Metrics

MetricSUVEN (2025)HESTERBIO (2025)
Cash & Equivalents i150.26M55.87M
Total Current Assets i754.72M1.95B
Total Current Assets % of Revenue i1,133.9%62.7%
Total Current Liabilities i234.86M1.25B
Total Current Liabilities % of Revenue i352.9%40.2%
Long-Term Debt iN/A1.39B
Long-Term Debt % of Revenue i0.0%44.6%
Total Shareholders Equity i1.10B3.27B
Retained Earnings i-6.01B2.37B
Retained Earnings % of Revenue i-9,024.8%76.2%
Property, Plant & Equipment i756.69M59.22M

Cash Flow Statement Comparison

MetricSUVEN (2025)HESTERBIO (2025)
Operating Cash Flow i-1.59B554.94M
Operating Cash Flow % of Revenue i-2,389.3%17.8%
Capital Expenditures i-372.76M2.74M
Free Cash Flow i-1.91B439.20M
FCF Margin i-2,875.4%14.1%
Debt Repayment iN/A-331.16M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSUVENHESTERBIO
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i263.72M8.51M
Float Shares i63.70M2.50M
% Held by Insiders i71.40%68.79%
% Held by Institutions i3.09%0.37%
% Held by Public i25.51%30.84%

Dividend Analysis & Yield Comparison: Suven Life Sciences Ltd. vs Hester Biosciences Ltd.

MetricSUVENHESTERBIO
Last 12-Month Dividend i₹0.00₹13.00
Last 12-Month Dividend Yield iN/A0.64%
3-Year Avg Annual Dividend i₹0.00₹10.33
3-Year Avg Dividend Yield iN/A0.37%
3-Year Total Dividends i₹0.00₹31.00
Ex-Dividend DateN/AAug 06, 2025